Research Article
Changes in Breast Cancer Presentation during COVID-19: Experience in an Urban Academic Center
Table 1
Patient population before COVID-19 (2019) and after COVID-19 (2020).
| Variable | 2019 population () | 2020 population () | value |
| Method of detection | | | | Self-exam | 19.80% | 26.0% | 0.0688 | Mammography | 67.0% | 60.0% | Palpability | 31.50% | 39.20% | 0.0533 | Neoadjuvant therapy | 8.30% | 10.20% | 0.4384 | Radiation therapy | 65.0% | 54% | <0.0001 | Age at presentation | 60.04 | 60.68 | 0.6171 | Type of surgery | | | | Breast conserving surgery | 69% | 66% | <0.8508 | Mastectomy | 31% | 34% | Histology | | | | IDC | 60.70% | 66.7% | 0.5822 | DCIS | 20.9% | 16.7% | ILC | 10.6% | 8.10% |
|
|